Arabic Arabic English English French French German German
dark

INMUNE BIO, INC. ANNOUNCES $40 MILLION REGISTERED DIRECT OFFERING

INmune Bio, Inc. today announced that it has entered into a definitive agreement with one healthcare focused institutional investor and one family office for the purchase and sale of 1,818,182 shares of its common stock at a price of $22.00 per share. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Health Volunteer Center Participates in Serving Pilgrims during this Year’s Hajj Season

Next Post

Kintor Pharmaceutical Receives IND Clearance by the U.S. FDA for GT20029 to Treat Androgenetic Alopecia and Acne

Related Posts
Total
0
Share